Physician profile
Surinder S Thind
NPI 1568503639
$887.80
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $684 · 2020: $117 · 2021: $19.02 · 2023: $19.86 · 2024: $47.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $210.28 | 2019-2023 | Amplatzer Amulet |
| Sanofi-Aventis U.S. LLC | $178.54 | 2019 | |
| Novartis Pharmaceuticals Corporation | $89.65 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.70 | 2019 | |
| Amgen INC. | $75.38 | 2019-2020 | |
| Pfizer INC. | $60.95 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $47.40 | 2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $45.78 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $40.65 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.48 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surinder Thind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.